Trials / Conditions / Epithelial Tumors, Malignant
Epithelial Tumors, Malignant
6 registered clinical trials studyying Epithelial Tumors, Malignant — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors NCT07400263 | Peking University People's Hospital | N/A |
| Withdrawn | Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytor NCT05375825 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041 | Myeloid Therapeutics | Phase 1 |
| Recruiting | Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Ly NCT05141474 | Vall d'Hebron Institute of Oncology | EARLY_Phase 1 |
| Completed | NHS-IL12 for Solid Tumors NCT01417546 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastat NCT01207323 | Genentech, Inc. | Phase 1 |